Read more on P-BCMA-ALLO1 “showing promise in multiple myeloma” as featured in GEN | View our supporting IMS data here

Mark Gergen to assume role of Executive Chairman of the Board of Directors of Poseida ; Kristin Yarema , Ph.D., currently President, Cell Therapy , to be appointed President and CEO SAN DIEGO , Oct. 9, 2023 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene